mtg201
Gene therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 31, 2019 (NCT04013334)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Dickkopf-related protein 3Supplementation
supplementation - Dkk-3
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04013334 | Phase 2 | Jul 31, 2019 | Baylor University, Momotaro-Gene Inc., Synteract, Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baylor University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Momotaro-Gene Inc. | For profit | 1 | 1 | 1 | 2019 |
| Synteract, Inc. | For profit | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1